8-KEarnings & ResultsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Financial Results (Jul 22, 2020)

Filed July 22, 2020For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) filed an 8-K on July 22, 2020, primarily to announce its financial results for the fiscal quarter ended June 27, 2020. The filing incorporates by reference the press release detailing these results, which is attached as Exhibit 99.1. Investors should note that this information is typically "furnished" rather than "filed," meaning it's not subject to the same liability provisions as other parts of SEC filings. The press release itself contains the crucial financial performance data for the quarter. While the 8-K document focuses on the filing mechanics and includes a standard "Cautionary Statement Regarding Forward-Looking Statements" highlighting potential risks, investors will need to refer to the attached press release (Exhibit 99.1) for the actual financial figures and management's commentary on performance, including any impact from the ongoing COVID-19 pandemic and strategic updates.

Key Highlights

  • 1Announcement of Q2 2020 financial results via press release (Exhibit 99.1).
  • 2The 8-K filing date is July 21, 2020, with the event date of the announcement being July 22, 2020.
  • 3Financial results information is furnished under Item 2.02 and is incorporated by reference via Exhibit 99.1.
  • 4Information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act.
  • 5The filing includes a standard 'Cautionary Statement Regarding Forward-Looking Statements' outlining potential risks and uncertainties.
  • 6Key risks mentioned include the duration/severity of the COVID-19 pandemic, technological change, economic conditions, and acquisition integration (e.g., QIAGEN N.V.).

Frequently Asked Questions

The actual financial results for the fiscal quarter ended June 27, 2020, are detailed in the press release attached as Exhibit 99.1 to this Form 8-K filing. This press release is incorporated by reference and contains the specific performance metrics.

Information that is 'furnished' under Item 2.02 (like financial results press releases) is generally not subject to the liabilities associated with Section 18 of the Securities Exchange Act of 1934. This means that while the information is provided to investors, the company faces less stringent liability for any inaccuracies in that specific furnished information compared to formally 'filed' information.

This particular 8-K filing document itself does not contain the specific financial numbers. It serves as a notification and attachment vehicle for the press release (Exhibit 99.1), which is where the detailed Q2 2020 financial results and operational commentary can be found.

The filing highlights several potential risks, including the ongoing COVID-19 pandemic, the need for new product development, significant technological changes, general economic conditions, customer spending policies, government funding, international operations, intellectual property protection, regulatory changes, and the successful integration of acquisitions, such as the pending acquisition of QIAGEN N.V.